Activity-dependent metabolic vulnerability in the APPPS1 Alzheimer’s disease mouse model during isoflurane anesthesia

BIOMEDICINE & PHARMACOTHERAPY · Published 2026-07-14 · DOI 10.1016/j.biopha.2026.119608

Free full text

Authors (8)

Jonas Schunack, Georg Riepe, Kathrin Textoris-Taube, Iwona Wallach, Michael Mülleder, Agustin Liotta, Marina Jendrach, Nikolaus Berndt

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Schunack, J., Riepe, G., Textoris-Taube, K., et al. (2026). Activity-dependent metabolic vulnerability in the APPPS1 Alzheimer’s disease mouse model during isoflurane anesthesia. BIOMEDICINE & PHARMACOTHERAPY. https://doi.org/10.1016/j.biopha.2026.119608

Related articles

• 2-deoxy-d-ribose: A multifaceted player at the crossroads of cancer metabolism · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Tailoring pH-responsive charge-conversional interfaces in ionizable lipid-based nanoliposomes for synchronized co-delivery and synergistic therapy of triple-negative breast cancer · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Preserved motor function and prolonged sensory local anesthesia with novel PLGA microparticles co-encapsulating lidocaine and capsaicin · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Iron–quercetin complex induces ex vivo proteomic remodeling in circulating proangiogenic cells derived from human peripheral blood mononuclear cells · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Acetonic extract of Saskatoon berry attenuates amyloid-associated neurotoxicity in cellular and Drosophila melanogaster Alzheimer’s disease models · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Design of sunflower trypsin inhibitor 1 derived probes targeting the LDLR and evaluation of their brain delivery · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• The chalcone derivative DN-053 attenuates renal fibrosis and inhibits p38 MAPK and STAT3 signaling in renal fibroblasts · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Urinary biomarkers in muscle-invasive bladder cancer: Current state and open opportunities for neoadjuvant chemotherapy response prediction and patient stratification · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• Fluorinated isoindolinone–amino acid hybrids possessing antiproliferative and antitumor activity in vitro and in vivo · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal
• O-GlcNAc transferase as an oncogenic regulator in hematologic malignancies: Mechanisms, disease contexts, and therapeutic perspectives · BIOMEDICINE & PHARMACOTHERAPY · 2026 · Same journal